The Luxembourg Patent for Invention represents Europe's most stringent pharmaceutical-grade innovation certification. Our formula for alleviating allergies and chronic inflammation has undergone comprehensive examination by the Luxembourg Intellectual Property Office (Patent No.LU505637), demonstrating global novelty, scientific creativity, and industrial applicability.

This formula can be used to address common allergic reactions and chronic inflammatory conditions, including: food allergies, respiratory allergies, skin allergies, chronic pneumonia, chronic pubic osteitis, chronic arthritis, chronic gastroenteritis, etc. It is suitable for immunocompromised children, individuals with seasonal allergies, and those with weakened immune systems.